22 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
of these products will depend on reimbursement policies and may be affected by future healthcare
S-20
reform measures. Government authorities and third … products that we develop, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
regulatory authorities, market acceptance and sales of these products will depend on reimbursement policies and may be affected by future healthcare reform … pressures in connection with the sale of any products that we develop, due to the trend toward managed healthcare, the increasing influence of health
8-K
ZYME
Zymeworks Inc.
1 Apr 24
Departure of Directors or Certain Officers
9:00am
, pharmaceutical and healthcare sectors. Mr. Galbraith received his B.Comm. from the University of British Columbia.
The compensatory and other material terms
8-K
EX-99.1
ccvex
4 Jan 24
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
6:31am
8-K
xqwooj
18 May 23
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
8:40am
8-K
EX-10.1
7knym6xf9ce
16 May 23
Entry into a Material Definitive Agreement
8:30am
424B5
4xn 479rxonal5f9f9
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
85crtjyw9m4416su
8 May 23
Prospectus supplement for primary offering
5:18pm
DEF 14A
8mkc49nbps ex
25 Nov 22
Definitive proxy
6:16am
424B5
pph1ic7
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
j8ybyihpul
8 Nov 22
Quarterly report
4:09pm
424B5
hr0mg4j9hpl
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
v4ht xkk3ryig01jvmy
13 Oct 22
Prospectus supplement for primary offering
4:56pm